𝔖 Bobbio Scriptorium

✦ LIBER ✦

Lp-PLA2 and risk of atherosclerotic vascular disease

✍ Scribed by Robert S Rosenson

Book ID: 117306486
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 334 KB
Volume: 375
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(10)60488-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lp-PLA2: Inflammatory Biomarker of Vascu

Lp-PLA2: Inflammatory Biomarker of Vascular Risk in Multiple Sclerosis

✍ Sternberg, Zohara; Drake, Alison; Sternberg, Daniel S.; Benedict, Ralph H. B.; L 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 490 KB

Lp(a) lipoprotein and risk of atheroscle

Lp(a) lipoprotein and risk of atherosclerotic/thrombotic disease

✍ K. Berg 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 449 KB

Lp-PLA2– a novel risk factor for high-ri

Lp-PLA2– a novel risk factor for high-risk coronary and carotid artery disease

✍ K. C. Epps; R. L. Wilensky 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

92. Lp(a) lipoprotein and risk of athero

92. Lp(a) lipoprotein and risk of atherosclerotic/thrombotic disease

✍ K. Berg 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 257 KB

LP-PLA2: A NEW MARKER OF CARDIOVASCULAR

LP-PLA2: A NEW MARKER OF CARDIOVASCULAR RISK

✍ Eva Motyková; Lukáš Zlatohlávek; Martina Prusíková; Michal Vrablík; Ludmila Vaší 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Therapeutic Options to Reduce Lp-PLA2 Le

Therapeutic Options to Reduce Lp-PLA2 Levels and the Potential Impact on Vascular Risk Reduction

✍ Koto Ishida MD, Brett Cucchiara MD 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 151 KB